United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - metformin hydrochloride - modified-release tablet - 1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - metformin hydrochloride - modified-release tablet - 1gram

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merckp -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

merckp -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: hypromellose; povidone; magnesium stearate - metformin is indicated in the treatment of type 2 diabetes mellitus not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. metformin may be used as initial therapy or in sulphonylurea failure, either alone or in combination with a sulphonylurea or as adjuvant therapy in insulin-dependent diabetes.

Ireland - English - HPRA (Health Products Regulatory Authority)

merck serono limited - metformin hydrochloride - powder for oral solution - 1000 milligram

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: hypromellose; microcrystalline cellulose; magnesium stearate; carmellose sodium - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. glucophage xr may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.